This guideline focuses on managing prolactin-secreting pituitary adenomas in adults, excluding pregnancy. The panel recommends cabergoline as the first-choice pharmacological treatment, with bromocriptine as an alternative for intolerant patients. Medication and surgery are suggested as suitable...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.